Free Trial
NASDAQ:OPGN

OpGen (OPGN) Stock Price, News & Analysis

OpGen logo
$4.70 +0.10 (+2.17%)
As of 07/17/2025 03:37 PM Eastern

About OpGen Stock (NASDAQ:OPGN)

Key Stats

Today's Range
$3.72
$4.75
50-Day Range
$4.05
$5.02
52-Week Range
$0.53
$5.25
Volume
2,447 shs
Average Volume
8,920 shs
Market Capitalization
$47.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OPGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OpGen and its competitors with MarketBeat's FREE daily newsletter.

OPGN Stock News Headlines

OpGen Forms Joint Venture with European Bank
Altucher: Turn $900 into $108,000 in just 12 months?
Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this marks the beginning of “Trump’s Great Gain,” a new crypto bull phase driven by emerging federal policies. He believes certain altcoins could turn $900 into $108,000 — and reveals everything in a new presentation.
OpGen Appoints New COO and Company Secretary
OPGN Stock Earnings: OpGen Reported Results for Q2 2024
See More Headlines

OPGN Stock Analysis - Frequently Asked Questions

OpGen's stock was trading at $0.5950 at the start of the year. Since then, OPGN stock has increased by 689.9% and is now trading at $4.70.

OpGen, Inc. (NASDAQ:OPGN) released its earnings results on Thursday, August, 10th. The medical research company reported ($9.30) EPS for the quarter, missing analysts' consensus estimates of ($7.10) by $2.20. The medical research company earned $0.74 million during the quarter, compared to analysts' expectations of $0.90 million.

OpGen shares reverse split before market open on Monday, May 20th 2024.The 1-10 reverse split was announced on Monday, May 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

OpGen (OPGN) raised $17 million in an initial public offering on Tuesday, May 5th 2015. The company issued 2,900,000 shares at $5.50-$6.50 per share. Maxim Group acted as the underwriter for the IPO and National Securities was co-manager.

Shares of OPGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that OpGen investors own include NVIDIA (NVDA), Meta Platforms (META), CymaBay Therapeutics (CBAY), Advanced Micro Devices (AMD), Pfizer (PFE), Sorrento Therapeutics (SRNE) and Broadcom (AVGO).

Company Calendar

Last Earnings
8/10/2023
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:OPGN
CIK
1293818
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.67 million
Net Margins
-1,140.36%
Pretax Margin
-742.42%
Return on Equity
N/A
Return on Assets
-287.58%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.45
Quick Ratio
5.45

Sales & Book Value

Annual Sales
$2.67 million
Price / Sales
17.70
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($11.55) per share
Price / Book
-0.41

Miscellaneous

Outstanding Shares
10,068,000
Free Float
4,696,000
Market Cap
$47.32 million
Optionable
Not Optionable
Beta
-1.66

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:OPGN) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners